WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | 1/100-1/500 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | NACHT, LRR and PYD domains-containing protein 6, Angiotensin II/vasopressin receptor, PYRIN-containing APAF1-like protein 5-like, Nlrp6, Nalp6, Pypaf5 |
Entrez GeneID | 101613 |
WB Predicted band size | 97.4kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human, Mouse, Rat |
Immunogen | This Mouse Nlrp6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 343-372 amino acids from the Central region of mouse Nlrp6. |
Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是3篇关于小鼠NLRP6抗体的参考文献及其摘要概括:
---
1. **文献名称**:*NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis*
**作者**:Elinav E, Strowig T, Kau AL, et al.
**摘要**:该研究通过NLRP6基因敲除小鼠模型,揭示了NLRP6炎症小体对肠道菌群组成的调控作用及其在结肠炎发病中的关键角色。研究中使用NLRP6抗体验证了蛋白表达缺失,并发现NLRP6缺陷导致肠道菌群失调,加剧化学诱导性结肠炎。
2. **文献名称**:*Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity*
**作者**:Henao-Mejia J, Elinav E, Jin C, et al.
**摘要**:本文探讨了NLRP6炎症小体与非酒精性脂肪肝(NAFLD)及肥胖的关系。通过NLRP6抗体检测小鼠肝脏及肠道组织中的蛋白表达,发现NLRP6缺失导致肠道菌群改变,并通过“肠-肝轴”促进代谢综合征的发展。
3. **文献名称**:*NLRP6 modulates neutrophil homeostasis in bacterial pneumonia*
**作者**:Karmarkar D, Rock KL.
**摘要**:研究利用NLRP6特异性抗体分析小鼠肺部免疫细胞,发现NLRP6通过调控中性粒细胞活性影响细菌性肺炎的病理进程。实验表明,NLRP6缺陷小鼠中性粒细胞功能异常,导致肺炎链球菌感染后死亡率升高。
---
以上文献均涉及NLRP6抗体在蛋白表达验证或功能研究中的应用,涵盖肠道炎症、代谢疾病及感染免疫等领域。如需具体实验细节,建议查阅原文方法学部分。
Mouse NLRP6 (NACHT, LRR, and PYD domains-containing protein 6) is a member of the NOD-like receptor (NLR) family, which plays a critical role in innate immunity by functioning as a pattern recognition receptor (PRR). It is primarily expressed in intestinal epithelial cells and immune cells, where it contributes to the formation of inflammasomes—multiprotein complexes that activate caspase-1 and drive the maturation of pro-inflammatory cytokines like IL-18. NLRP6 has been implicated in maintaining mucosal homeostasis, regulating gut microbiota composition, and modulating host defense against pathogens. Studies in mice have shown that NLRP6 deficiency can lead to dysbiosis, increased susceptibility to colitis, and altered responses to metabolic or inflammatory challenges.
Mouse NLRP6 antibodies are essential tools for investigating these biological processes. They are widely used in techniques such as Western blotting, immunohistochemistry, and immunofluorescence to detect NLRP6 expression and localization in tissues or cells. These antibodies help researchers explore NLRP6's regulatory mechanisms in diseases like inflammatory bowel disease (IBD), metabolic syndrome, and neuroinflammation. However, functional studies have revealed context-dependent roles of NLRP6. with some reports suggesting it may also suppress NF-κB and MAPK signaling pathways. Due to its complex interplay with microbiota and immune signaling, high-specificity anti-NLRP6 antibodies are critical for distinguishing its activity from other NLRs and validating findings in knockout mouse models.
×